On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Horizon Therapeutics

FunderResearch funding and supported work

Horizon Therapeutics is a funder indexed in ScholarIQ from OpenAlex.

What is known about Horizon Therapeutics?

ScholarIQrecord summary

Irish tax-registered pharmaceutical

How many works does Horizon Therapeutics have?

ScholarIQindexed works

Horizon Therapeutics has 838 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Horizon Therapeutics?

ScholarIQopenalex

The OpenAlex for Horizon Therapeutics is on the source record.

What are the most-cited papers on Horizon Therapeutics?

ScholarIQmost cited works
Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction
Rahul Aggarwal, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones, Michaela Mattheus, Mark C. Petrie, Dominik Steubl, Mikhail Sumin, Vikram Thanam, Jacob A. Udell, Javed Butler
Nature Cardiovascular Research. 20253 CitationsOPEN ACCESS
470M+ articles · 14-day free trial